High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Some hormones can stimulate the growth of some types of cancer cells. Hormone
therapy using megestrol may fight cancer by reducing the production of these hormones.
PURPOSE: Phase I/II trial to study the effectiveness of high-dose megestrol in treating
patients with metastatic breast cancer, endometrial cancer, or mesothelioma which cannot be
treated with surgery or radiation therapy.